[go: up one dir, main page]

CN104606204A - Febrifuge for children - Google Patents

Febrifuge for children Download PDF

Info

Publication number
CN104606204A
CN104606204A CN201510071108.4A CN201510071108A CN104606204A CN 104606204 A CN104606204 A CN 104606204A CN 201510071108 A CN201510071108 A CN 201510071108A CN 104606204 A CN104606204 A CN 104606204A
Authority
CN
China
Prior art keywords
fever
children
parts
dexamethasone
dipyridamole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510071108.4A
Other languages
Chinese (zh)
Inventor
陈燕
蒋新军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan University of Chinese Medicine
Original Assignee
Hunan University of Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan University of Chinese Medicine filed Critical Hunan University of Chinese Medicine
Priority to CN201510071108.4A priority Critical patent/CN104606204A/en
Publication of CN104606204A publication Critical patent/CN104606204A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明属于医药技术领域,具体是涉及到一种儿童退烧药,由如下重量组分组成:地塞米松 0.5-3份,潘生丁8-25份,去痛片 50-150份,生理盐水 1万-2万份;本发明的潘生丁具有扩张血管的功能,血管扩张,血液流速增快,有利于散热;地塞米松具有抗炎、抗病毒、抗休克、防过敏的功效;去痛片可退热并缓解轻、中度疼痛,本发明的三种有效组分合并使用,协同发挥作用,且克服了各自的缺陷,高热不退者使用一到两次,即可退热,且能够达到持续退热的功效。The invention belongs to the technical field of medicine, and in particular relates to an antipyretic for children, which consists of the following components by weight: 0.5-3 parts of dexamethasone, 8-25 parts of dipyridamole, 50-150 parts of Qutong Tablets, and 10,000 parts of normal saline -20,000 copies; dipyridamole of the present invention has the function of dilating blood vessels, blood vessels dilate, and blood flow speed increases, which is beneficial to heat dissipation; dexamethasone has anti-inflammatory, anti-viral, anti-shock, and anti-allergic effects; Qutong Tablets can be withdrawn heat and relieve mild and moderate pain, the three effective components of the present invention are used in combination to play a synergistic role, and overcome their respective defects. Those with persistent high fever can reduce their fever after using it once or twice, and can achieve sustained Antipyretic effect.

Description

儿童退烧药antipyretics for children

技术领域 technical field

本发明属于医药技术领域,具体是涉及到一种儿童退烧药。 The invention belongs to the technical field of medicine, and in particular relates to an antipyretic for children.

背景技术 Background technique

高热是儿童常见的疾病,常常不容易控制,且易发生反复性高热。一般用退烧药进行控制,退烧药的剂型主要有口服药、针剂、贴剂。 High fever is a common disease in children, often difficult to control, and prone to recurrent high fever. Generally, antipyretics are used for control, and the dosage forms of antipyretics mainly include oral medicines, injections, and patches.

(1)口服药:儿童常常难以咽下口服药。 (1) Oral medicine: Children often have difficulty swallowing oral medicine.

(2)针剂:儿童血管较细小,难以穿刺,且儿童好动,容易导致穿刺失败,造成淤血,给儿童带来痛苦。 (2) Injection: Children's blood vessels are small and difficult to puncture, and children are active, which may easily lead to puncture failure, cause congestion, and bring pain to children.

(3)贴剂:皮肤对贴剂的吸收较慢,降温缓慢,不能用于高热迅速降温。 (3) Patch: The skin absorbs the patch slowly and cools down slowly, so it cannot be used for rapid cooling of high fever.

退烧药是一种可以通过调节人体机能使人体体表血管扩张、进而借助于出汗等过程使散热增加,同时抑制寒战、使机体产热减少的药品。它能有效地控制发烧,使体温降低,但不能根本解除引起发热的原因。发烧是许多疾病共有的症状之一,治疗发烧不论病因病情地使用退烧药是不行的。退烧药有毒副作用。 Antipyretics are medicines that can dilate blood vessels on the human body surface by regulating human body functions, and then increase heat dissipation through processes such as sweating, while suppressing chills and reducing body heat production. It can effectively control fever and lower body temperature, but it cannot fundamentally eliminate the cause of fever. Fever is one of the common symptoms of many diseases. It is not acceptable to use antipyretics to treat fever regardless of the etiology and condition. Antipyretics have toxic side effects.

退烧药很常用,但其毒副作用也是常见的。诸如药疹、胃肠道反应、血液系统反应及对肝肾功能的损害等,尤其是当久用或过量使用此类药物时,毒副作用更加显著。 Antipyretics are commonly used, but their toxic side effects are also common. Such as drug eruption, gastrointestinal tract reaction, blood system reaction and damage to liver and kidney function, etc., especially when such drugs are used for a long time or excessively, the toxic and side effects are more significant.

目前市场上常见的儿科退烧药由以下几种: Common pediatric antipyretics currently on the market include the following:

1、对乙酰氨基酚,是一种安全的退热药,其退热效果与剂量成正比,但剂量过大会引起肝肾功能损害,因此,使用时应严格遵守剂量,不能过量。剂量为每公斤体重10~15毫克,4~6小时一次。代表药如泰诺林、小儿百服宁滴剂等。 1. Acetaminophen is a safe antipyretic drug. Its antipyretic effect is directly proportional to the dosage, but excessive dosage can cause damage to liver and kidney function. The dose is 10-15 mg per kg body weight, once every 4-6 hours. Representative drugs such as Tylenol, Xiaoerbaifuning drops and so on.

2、柴胡注射液:为从中药柴胡中提取的注射剂,该药退热作用较慢且弱,副作用少,但需注意,有过敏体质的孩子应慎用。 2. Bupleurum Injection: It is an injection extracted from the traditional Chinese medicine Bupleurum. The antipyretic effect of this medicine is slow and weak, and there are few side effects. However, it should be noted that children with allergies should use it with caution.

3、布洛芬:为非甾体类抗炎药,具有明显的解热镇痛作用,副作用少,本品可以代替肌肉注射退热药,适用于感染性疾病所致高热患儿使用。剂量为每公斤体重5~10毫克,每6~8小时一次。代表药为托恩口服溶液、小儿美林糖浆。 3. Ibuprofen: It is a non-steroidal anti-inflammatory drug, which has obvious antipyretic and analgesic effects, and has few side effects. This product can replace intramuscular injection of antipyretic drugs, and is suitable for children with high fever caused by infectious diseases. The dose is 5-10 mg per kg body weight, once every 6-8 hours. The representative medicines are Torn Oral Solution and Pediatric Merrill Syrup.

4、安痛定,又名复方氨基比林,是临床上最常用的一种退热药,但若短期内反复多次注射本品易致急性粒细胞缺乏症,有致命危险,对于某些患儿来说,本药有诱发急性溶血性贫血,皮疹等副作用,此外,如注射本品剂量过大会使孩子出汗过多,体温骤降,易引起虚脱,因此,复方氨基比林婴幼儿禁用,年长儿慎用。 4. Antongding, also known as compound aminopyrine, is the most commonly used antipyretic drug in clinical practice. However, repeated injections of this product in a short period of time can easily cause acute agranulocytosis, which is fatal. For some For children, this drug has side effects such as inducing acute hemolytic anemia and skin rash. In addition, if the dose of this product is injected too much, the child will sweat excessively, and the body temperature will drop suddenly, which will easily cause collapse. Disabled, use with caution in older children.

5、安乃近:主要副作用为肾毒性、胃肠道出血、严重皮疹,致死性粒细胞缺乏为其最严重副作用。目前有很多国家禁止使用或限制使用本品,但国内还有的地方医院还在使用,值得引起高度重视。 5. Analgin: The main side effects are nephrotoxicity, gastrointestinal bleeding, and severe skin rash, and fatal agranulocytosis is the most serious side effect. At present, many countries prohibit or restrict the use of this product, but some local hospitals in China still use it, which deserves great attention.

6、阿司匹林:这是一种历史悠久的退烧药,退热作用较强,但副作用大,目前在国内儿科趋于淘汰,使用时,应遵照医嘱,按时按量服用。 6. Aspirin: This is an antipyretic with a long history. It has a strong antipyretic effect, but it has a lot of side effects. At present, it is tending to be eliminated in domestic pediatrics.

7、中成药的退热药物。 7. Antipyretic drugs of Chinese patent medicines.

发明内容 Contents of the invention

本发明要解决的技术问题是提供一种儿童退烧药,其退烧作用快,毒副作用小,且能够达到持续退热的功效。 The technical problem to be solved by the present invention is to provide an antipyretic medicine for children, which has fast antipyretic effect, less toxic and side effects, and can achieve continuous antipyretic effect.

为解决上述技术问题,本发明的内容是由如下重量组分组成: In order to solve the problems of the technologies described above, content of the present invention is made up of following weight components:

地塞米松 0.5-3份, Dexamethasone 0.5-3 parts,

潘生丁8-25份, Persantine 8-25 parts,

去痛片 50-150份, Qu Pain Tablets 50-150 copies,

生理盐水 1万-2万份。 10,000-20,000 parts of normal saline.

优选的,所述儿童退烧药由如下重量组分组成: Preferably, the antipyretic for children consists of the following components by weight:

地塞米松 1-2份, 1-2 parts of dexamethasone,

潘生丁12.5-20份, Persantine 12.5-20 parts,

去痛片75-125份, 75-125 servings of Pain Relief Tablets,

生理盐水1万-1.5万份。 10,000-15,000 copies of normal saline.

最优选的,所述儿童退烧药由如下重量组分组成: Most preferably, the antipyretic for children consists of the following components by weight:

地塞米松1.5份, 1.5 parts of dexamethasone,

潘生丁16份, 16 parts of dipyridamole,

去痛片100份, 100 copies of Pain Relief Tablets,

生理盐水1万份。 10,000 parts of normal saline.

本发明的地塞米松,又叫德沙美松、氟甲强的松龙是抗炎、抗过敏药物。主要作为危重疾病的急救用药和各类炎症的治疗。药理作用主要是抗炎、抗毒、抗过敏、抗风湿,临床使用较广泛。用于退烧时,能够抑制致热源的释放,降低体温中枢的敏感性,极易自消化道吸收。其具有以下功能:抗炎作用和免疫抑制作用。 The dexamethasone of the present invention, also known as Dexamethasone and Flumeprednisolone, are anti-inflammatory and anti-allergic drugs. It is mainly used as emergency medicine for critical illness and treatment of various inflammations. The pharmacological effects are mainly anti-inflammatory, anti-toxic, anti-allergic, anti-rheumatic, and are widely used clinically. When used to reduce fever, it can inhibit the release of pyrogens, reduce the sensitivity of the body temperature center, and is easily absorbed from the digestive tract. It has the following functions: anti-inflammatory and immunosuppressive effects.

地塞米松的常见不良反应有以下几类: Common side effects of dexamethasone include the following:

1.长程使用可引起以下副作用:医源性库欣综合征面容和体态、体重增加、下肢浮肿、紫纹、易出血倾向、创口愈合不良、痤疮、月经紊乱、肱或股骨头缺血性坏死、骨质疏松及骨折、肌无力、肌萎缩、低血钾综合征、胃肠道刺激、胰腺炎、消化性溃疡或穿孔,儿童生长受到抑制、青光眼、白内障、良性颅内压升高综合征、糖耐量减退和糖尿病加重。 1. Long-term use can cause the following side effects: iatrogenic Cushing syndrome appearance and posture, weight gain, lower extremity edema, purple streaks, easy bleeding tendency, poor wound healing, acne, menstrual disorders, avascular necrosis of the humerus or femoral head, bone osteoporosis and fractures, muscle weakness, muscle atrophy, hypokalemia syndrome, gastrointestinal irritation, pancreatitis, peptic ulcer or perforation, growth inhibition in children, glaucoma, cataract, benign intracranial hypertension syndrome, diabetes Impaired tolerance and exacerbation of diabetes.

2.患者可出现精神症状:欣快感、激动、谵妄、不安、定向力障碍,也可表现为抑制。精神症状由易发生与患慢性消耗性疾病的人及以往有过精神不正常者。 2. Patients may present with psychiatric symptoms: euphoria, agitation, delirium, restlessness, disorientation, and depression. Mental symptoms are prone to occur with people suffering from chronic wasting diseases and those who have had mental disorders in the past.

3.并发感染为肾上腺皮质激素的主要不良反应。 3. Concurrent infection is the main adverse reaction of adrenocortical hormone.

4.糖皮质激素停药综合征。 4. Glucocorticoid withdrawal syndrome.

地塞米松用于高热降温,但有并发症,如降低身体免疫功能,阻碍抗体形成,使某些致病菌趁机生长繁殖,引起二次感染或某些炎性疾病等,体温骤然下降并大量出汗,容易引起虚脱。 Dexamethasone is used to cool down high fever, but there are complications, such as reducing the body's immune function, hindering the formation of antibodies, causing some pathogenic bacteria to take advantage of the opportunity to grow and reproduce, causing secondary infections or certain inflammatory diseases, etc. The body temperature suddenly drops and a large number of Sweating can easily cause collapse.

本发明的潘生丁,别名双嘧啶胺醇,双嘧达莫(Dipyridamole),双嘧达莫哌醇定,系非硝酸酯类冠状动脉扩张剂,具有扩张冠状血管、促进侧支循环形成和轻度抗凝作用。潘生丁具有抗病毒的作用,通过抑制二氧嘧啶核苷通过细胞膜进入FL细胞,并能选择性抑制病毒PNA的合成,从而能完全抑制病毒特异的增殖过程。其常见副作用为乏力、头痛、眩晕、昏厥、呕吐、腹泻、脸红、皮疹、瘙痒和胃肠道不适等,在临床上通常认为本品不能与其他药物混合注射。 Dipyridamole of the present invention, alias dipyridamole, dipyridamole (Dipyridamole), dipyridamole, is a non-nitrate coronary artery dilator, which has the functions of dilating coronary blood vessels, promoting the formation of collateral circulation and mild Anticoagulant effect. Dipyridamole has an antiviral effect, by inhibiting the entry of dioxypyrimidine nucleosides into FL cells through the cell membrane, and selectively inhibiting the synthesis of viral PNA, thereby completely inhibiting the virus-specific proliferation process. Its common side effects are fatigue, headache, dizziness, fainting, vomiting, diarrhea, flushing, rash, itching and gastrointestinal discomfort, etc. It is usually considered that this product cannot be mixed with other drugs for injection in clinical practice.

潘生丁一般不用于退烧,用于退烧也仅可降温,但是伴有并发症,如乏力、头痛、眩晕、昏厥、胃肠道不适、扁桃体炎、支气管炎、支气管肺炎等。 Dipyridamole is generally not used for reducing fever, and it can only reduce temperature when used for reducing fever, but it is accompanied by complications, such as fatigue, headache, dizziness, fainting, gastrointestinal discomfort, tonsillitis, bronchitis, bronchopneumonia, etc.

本发明的去痛片为复方制剂,其组份为:每片由氨基比林150mg、非那西丁150mg、咖啡因50mg、苯巴比妥15mg组成。去痛片需要避免与其它非甾体抗炎药,包括选择性COX-2抑制剂合并用药,因为在使用所有非甾体抗炎药治疗过程中的任何时候,都可能出现胃肠道出血、溃疡和穿孔的不良反应,其风险可能是致命的。 The Qutong tablet of the present invention is a compound preparation, and its components are as follows: each tablet is composed of 150 mg of aminopyrine, 150 mg of phenacetin, 50 mg of caffeine and 15 mg of phenobarbital. Qutong tablets need to be avoided in combination with other non-steroidal anti-inflammatory drugs, including selective COX-2 inhibitors, because gastrointestinal bleeding, Adverse effects of ulceration and perforation, the risk of which can be fatal.

去痛片可用于高热降温,同时又有镇静功效,利于患儿休息。其一般不用于退烧,用于退烧时会造成消化系统副反应,如消化不良、恶心呕吐,皮肤反应如皮疹、瘙痒等。 Qutong tablets can be used to cool down high fever, and at the same time have a sedative effect, which is beneficial for children to rest. It is generally not used to reduce fever. When it is used to reduce fever, it will cause side effects of the digestive system, such as indigestion, nausea and vomiting, and skin reactions such as rash and itching.

本发明的所述生理盐水为重量浓度为0.85~0.9%的氯化钠溶液。 The physiological saline in the present invention is a sodium chloride solution with a weight concentration of 0.85-0.9%.

本发明的有益效果是,本发明的潘生丁具有扩张血管的功能,血管扩张,血液流速增快,有利于散热;地塞米松具有抗炎、抗病毒、抗休克、防过敏的功效;去痛片可退热并缓解轻、中度疼痛,具有镇静功效。三种有效组分合并使用,协同发挥作用,且克服了各自的缺陷,高热不退者使用一到两次,即可退热,且能够达到持续退热的功效。 The beneficial effects of the present invention are that dipyridamole of the present invention has the function of dilating blood vessels, blood vessels dilate, and blood flow speed increases, which is beneficial to heat dissipation; dexamethasone has anti-inflammatory, anti-viral, anti-shock, and anti-allergic effects; It can reduce fever and relieve mild and moderate pain, and has a sedative effect. The three effective components are used in combination to play a synergistic role, and overcome their respective defects. People with persistent high fever can reduce fever after using it once or twice, and can achieve the effect of continuous fever reduction.

具体实施方式 Detailed ways

实施例1 Example 1

本发明的儿童退烧药由地塞米松1.5mg,潘生丁16mg,去痛片100mg,生理盐水10ml组成。制备方法为,将地塞米松、潘生丁和去痛片研磨粉碎,放入生理盐水中溶解得到。 The antipyretic medicine for children of the present invention is composed of 1.5 mg of dexamethasone, 16 mg of dipyridamole, 100 mg of Qutong tablets and 10 ml of normal saline. The preparation method is that the dexamethasone, dipyridamole and Qutong tablets are ground and pulverized, and dissolved in physiological saline.

实施例2 Example 2

本发明的儿童退烧药由地塞米松1mg,潘生丁20mg,去痛片75mg,生理盐水15ml组成。制备方法同实施例1。 The antipyretic medicine for children of the present invention is composed of 1 mg of dexamethasone, 20 mg of dipyridamole, 75 mg of Qutong tablets and 15 ml of normal saline. The preparation method is the same as in Example 1.

实施例3 Example 3

本发明的儿童退烧药由地塞米松2mg,潘生丁12.5mg,去痛片125mg,生理盐水10ml组成。制备方法同实施例1。 The antipyretic medicine for children of the present invention is composed of 2 mg of dexamethasone, 12.5 mg of dipyridamole, 125 mg of Qutong tablets and 10 ml of normal saline. The preparation method is the same as in Example 1.

实施例4 Example 4

本发明的儿童退烧药由地塞米松0.5mg,潘生丁25mg,去痛片50mg,生理盐水10ml组成。制备方法同实施例1。 The antipyretic medicine for children of the present invention is composed of 0.5 mg of dexamethasone, 25 mg of dipyridamole, 50 mg of Qutong tablets and 10 ml of normal saline. The preparation method is the same as in Example 1.

实施例5 Example 5

本发明的儿童退烧药由地塞米松3mg,潘生丁8mg,去痛片150mg,生理盐水20ml组成。制备方法同实施例1。 The antipyretic medicine for children of the present invention is composed of 3 mg of dexamethasone, 8 mg of dipyridamole, 150 mg of Qutong tablets and 20 ml of normal saline. The preparation method is the same as in Example 1.

实施例6 Example 6

使用方法为:使用注射器将实施例1-5任一项得到的儿童退烧药经过儿童肛门导入直肠内。 The method of use is as follows: use a syringe to introduce the antipyretic medicine for children obtained in any one of Examples 1-5 into the rectum through the anus of the child.

实施例7 Example 7

使用方法为:利用一次性使用肛门管将实施例1-5任一项得到的儿童退烧药经过儿童肛门导入直肠内。 The method of use is as follows: the children's antipyretic medicine obtained in any one of Examples 1-5 is introduced into the rectum through the children's anus by using a disposable anal canal.

实施例8 Example 8

效果说明 Effect description

对78例高热者,于2015年1月在湖南中医药大学第二附属医院门诊部按照实施例7的方法使用实施例1制备的儿童退烧药,发现使用后有75例高热儿童恢复正常,降温率达96.15%。高热者主要表现为:体温处于39.1-40℃之间,高热不退或者高热反复;高热儿童恢复正常的主要表征为:体温处于36.5-37.5℃之间,不会出现高热反跳,且1次用药后降温持续时间约为18-24小时。若此后患儿体温处于36.5-37.5℃之间,说明退烧成功,若18-24小时后出现高热反跳,则说明退烧失败。需要考虑其他原因所致发热(如支原体感染等),需要通过血培养确定病因学的检查。 For 78 cases of high fever patients, in January 2015, in the outpatient department of the Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, the antipyretic medicine for children prepared in Example 1 was used according to the method of Example 7, and it was found that 75 cases of high fever children returned to normal after use. The rate reached 96.15%. The main manifestations of high fever are: body temperature is between 39.1-40°C, high fever persists or high fever is repeated; the main symptoms of high fever children returning to normal are: body temperature is between 36.5-37.5°C, there will be no rebound of high fever, and once The duration of cooling after administration is about 18-24 hours. If the child's body temperature is between 36.5-37.5 ℃, it means that the fever has been successfully reduced. If the high fever rebounds after 18-24 hours, it means that the fever has failed. Fever due to other causes (such as mycoplasma infection, etc.) needs to be considered, and blood cultures should be used to determine the etiology.

实施例9 Example 9

对比试验分析 Comparative test analysis

设计对比试验,即地塞米松、潘生丁、去痛片、泰诺林及布洛芬口服混悬液单独用药,以及本发明实施例1药物对儿童发烧进行退烧处理,进行对比分析,观察其疗效,观察患儿就诊第一次用药后对患儿退烧时间、退烧持续时间,及整个治疗周期的退烧结果、不良反应。具体结果见表1。 Design comparative test, namely dexamethasone, dipyridamole, Qutong Tablets, Tylenol and ibuprofen oral suspension are used alone, and the medicine of Example 1 of the present invention is used to reduce fever in children, carry out comparative analysis, and observe its curative effect , to observe the fever-reducing time and duration of the children's fever after the first medication, and the fever-reducing results and adverse reactions of the entire treatment cycle. The specific results are shown in Table 1.

表1     不同药物对高热患者退烧的影响表 Table 1 The effect of different drugs on fever reduction in patients with high fever

地塞米松、潘生丁、去痛片的用量按照其用于退烧的常见用量来使用。其中地塞米松的用量为2mg地塞米松溶于10ml生理盐水;潘生丁的用量为20mg溶于10ml生理盐水;去痛片(购于广东华南药业集团有限公司)、泰诺林(上海强生制药有限公司)、布洛芬口服混悬液(天大药业(珠海)有限公司)的用法按照其说明书进行。 The dosages of dexamethasone, dipyridamole, and Qutong tablets are used according to their usual dosages for reducing fever. Among them, the dosage of dexamethasone is 2mg dexamethasone dissolved in 10ml normal saline; the dosage of dipyridamole is 20mg dissolved in 10ml normal saline; Co., Ltd.), ibuprofen oral suspension (Tianda Pharmaceutical (Zhuhai) Co., Ltd.) according to its instructions.

退烧成功、退烧失败的表征见实施例8的说明。 Refer to the description of Example 8 for the characterization of successful and failed fever reduction.

地塞米松的2例不良反应的表征为,体温骤然下降并大量出汗,引起虚脱(心跳加快、呼吸急促、气短、胸闷、昏厥)。且有恶心、呕吐、反酸、食欲不振现象。 The 2 cases of adverse reactions of dexamethasone were characterized by a sudden drop in body temperature and profuse sweating, causing collapse (rapid heartbeat, shortness of breath, shortness of breath, chest tightness, fainting). And nausea, vomiting, acid reflux, loss of appetite phenomenon.

潘生丁的3例不良反应的表征为乏力、头痛、眩晕、昏厥、胃肠道不适等,其中1例还伴有扁桃体炎,1例伴有支气管炎。 The adverse reactions of dipyridamole in 3 cases were characterized by fatigue, headache, dizziness, fainting, and gastrointestinal discomfort, among which 1 case was accompanied by tonsillitis and 1 case was accompanied by bronchitis.

去痛片的2例不良反应的表征为消化不良、恶心呕吐,1例伴有皮疹、瘙痒。 Two cases of adverse reactions of Qutong Tablets were characterized by indigestion, nausea and vomiting, and one case was accompanied by rash and itching.

泰诺林的不良反应的表征为皮疹。 Tylenol adverse reactions are characterized by rash.

布洛芬口服混悬液的不良反应的表征为消化不良和皮疹。 Adverse reactions of ibuprofen oral suspension are characterized by dyspepsia and rash.

从表1中数据可以看出,相比应用地塞米松、潘生丁和去痛片对儿童进行退烧,应用本发明实施例1的药物对儿童进行退烧后,退烧时间短,持续时间长,退烧成功的概率更大,而且出现不良反应的概率更小。其卡方值和p值说明各药物退烧成功的概率有明显差别,出现不良反应的概率也有明显差别。即使相对于应用泰诺林及布洛芬口服混悬液对儿童进行退烧,本发明药物对儿童退烧的成功率也高,不良反应更小。 As can be seen from the data in Table 1, compared with the use of dexamethasone, dipyridamole and Qutong Tablets to reduce fever in children, after the medicine of Example 1 of the present invention is used to reduce fever in children, the fever reduction time is short, the duration is long, and the fever reduction is successful. The probability is higher, and the probability of adverse reactions is smaller. The chi-square value and p-value indicate that there is a significant difference in the probability of successful fever reduction of each drug, and there is also a significant difference in the probability of adverse reactions. Even compared with the use of Tylenol and ibuprofen oral suspension to reduce fever in children, the medicine of the present invention has a high success rate in reducing fever in children and has less adverse reactions.

所属领域的普通技术人员应当理解:以上所述仅为本发明的具体实施例而已,并不用于限制本发明,凡在本发明的精神和原则之内,所做的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。 Those of ordinary skill in the art should understand that: the above descriptions are only specific embodiments of the present invention, and are not intended to limit the present invention. Any modifications, equivalent replacements, and improvements made within the spirit and principles of the present invention etc., should be included within the protection scope of the present invention.

Claims (3)

1. child's febrifuge, is characterized in that, is made up of following components by weight percent:
Dexamethasone 0.5-3 part,
Persantin 8-25 part,
Somedon 50-150 part,
Normal saline 10,000-2 ten thousand parts.
2. child's febrifuge as claimed in claim 1, it is characterized in that, described child's febrifuge is made up of following components by weight percent:
Dexamethasone 1-2 part,
Persantin 12.5-20 part,
Somedon 75-125 part,
Normal saline 10,000-1.5 ten thousand parts.
3. child's febrifuge as claimed in claim 1 or 2, it is characterized in that, described child's febrifuge is made up of following components by weight percent:
Dexamethasone 1.5 parts,
Persantin 16 parts,
Somedon 100 parts,
Normal saline 10,000 parts.
CN201510071108.4A 2015-02-11 2015-02-11 Febrifuge for children Pending CN104606204A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510071108.4A CN104606204A (en) 2015-02-11 2015-02-11 Febrifuge for children

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510071108.4A CN104606204A (en) 2015-02-11 2015-02-11 Febrifuge for children

Publications (1)

Publication Number Publication Date
CN104606204A true CN104606204A (en) 2015-05-13

Family

ID=53141025

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510071108.4A Pending CN104606204A (en) 2015-02-11 2015-02-11 Febrifuge for children

Country Status (1)

Country Link
CN (1) CN104606204A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106727642A (en) * 2016-12-17 2017-05-31 郑州郑先医药科技有限公司 A kind of children's antipyretic
CN107773564A (en) * 2016-08-26 2018-03-09 康普药业股份有限公司 A kind of pharmaceutical composition of antipyretic-antalgic

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1586484A (en) * 2004-07-12 2005-03-02 北京瑞伊人科技发展有限公司 Dipyridamole soft capsule preparation and its preparing method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1586484A (en) * 2004-07-12 2005-03-02 北京瑞伊人科技发展有限公司 Dipyridamole soft capsule preparation and its preparing method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
侯美玉: "《感冒发汗能用止痛片吗?》", 《家庭医学》 *
王晓英: "《地塞米松退热时不同给药方式疗效观察》", 《包头医学院学报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107773564A (en) * 2016-08-26 2018-03-09 康普药业股份有限公司 A kind of pharmaceutical composition of antipyretic-antalgic
CN106727642A (en) * 2016-12-17 2017-05-31 郑州郑先医药科技有限公司 A kind of children's antipyretic

Similar Documents

Publication Publication Date Title
Batchelor et al. Formulations for children: problems and solutions
US10206919B2 (en) Use of levocetirizine and montelukast in the treatment of vasculitis
JPH04504579A (en) Treatment of symptoms and diseases
JP2022050545A (en) Methods and compositions for treating sepsis
US20200101067A1 (en) Use of levocetirizine and montelukast in the treatment of anaphylaxis
Auyeung et al. Successful treatment of Stevens–Johnson syndrome with cyclosporine and corticosteroid
CN104606204A (en) Febrifuge for children
Peters et al. Hyperosmolar therapy for the treatment of cerebral edema
CN111803488B (en) Application of atractylenolide II in preparation of anti-renal fibrosis medicine and anti-renal fibrosis medicine
CN101978983A (en) Chinese medicinal composition for treating acute upper respiratory infection and preparation method thereof
CN102198123B (en) Prescription and preparation method of ibuprofen miniature enema
CN113750205A (en) Traditional Chinese medicine composition for relieving and/or treating female reproductive system diseases
CN109966291A (en) Application of compound SB216763 in the preparation of medicine for preventing and/or treating cerebrovascular disease and its pharmaceutical composition
CN113425723B (en) Application of Pim1 small-molecule inhibitor in preparation of product for preventing and treating ankylosing spondylitis
CN106902121A (en) Application of the ticagrelor in anaphy lactoid purpura nephritis adjuvant therapy medicaments
CN117137897B (en) Application of Sofadone in Preparing Medications for Preventing/Treating Psoriasis
CN103463193B (en) A kind of Chinese medicine composition for the treatment of gynaecologic metrorrhagia
RU2611383C2 (en) Combined preparation for elimination of symptoms and treating acute respiratory viral infections and influenza
CN102204883B (en) Prescription and preparation method of promethazine hydrochloride miniature enema
Thakurdesai et al. S3542 Is It Safe to Take Your Dog’s Medication? A Case of Severe Drug-Induced Liver Injury Due to Self-Administration of Fenbendazole
Chen et al. Effects of Damage Control Resuscitation Combined with Alanyl Glutamine on Complications and Survival in Sufferers with Severe Multiple Trauma.
CN110840869A (en) The application of metformin in endometriosis drugs
Doggrell Introduction to pharmacology, and routes of drugs administration and absorption
Lin et al. Common Medicines Used after the Replantation of Amputated Fingers
WO2022204397A1 (en) Treatment of long haulers syndrome with niclosamide

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150513

RJ01 Rejection of invention patent application after publication